MedPath

The effect of ginger supplementation on pain and inflammatory factors

Not Applicable
Completed
Conditions
osteoarthritis.
Primary generalized (osteo)arthrosis
Registration Number
IRCT201112078321N1
Lead Sponsor
Yazd University of Medical Scieces
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
100
Inclusion Criteria

to complete the inform consent; the presence of medium knee pain between 40mm and 70 mm on a 100-mm visual analog scale (VAS) during the preceding 24 hours; the age between 50 and 70 years; absence of following conditions: inflammatory disease, metabolic disorder such as diabetes, dementia, rheumatoid arthritis, fibromyalgia, gout, cancer or other serious disease, signs or history of liver or kidney failure, asthma requiring treatment with steroids; treatment with oral corticosteroids within the prior 4 weeks; intraarticular knee depo-corticosteroids within the previous 3 months; prior treatment with immunosuppressive drugs such as penicillamine; arthroscopy of the target joint within the previous yea; significant injury to the target joint within the previous 6 months; fever >38 degree C at screening; allergy to ginger. Exclusion criteria: serious complications; consumption of vitamin-mineral supplements or other nutritional supplements; consumption of analgesics.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain. Timepoint: before the intervention and 12 weeks after the end of treatment. Method of measurement: visual analoge scale.
Secondary Outcome Measures
NameTimeMethod
Some pro-inflammatory cytokins. Timepoint: before the intervention and after 12 weeks. Method of measurement: ELISA kit.
© Copyright 2025. All Rights Reserved by MedPath